INTRODUCTION AND METHODS: A pentaacyl and diphosphoryl lipid A molecule found in the lipid A isolated from Porphyromonas gingivalis lipopolysaccharide (LPS) was chemically synthesized, and its characteristics were evaluated to reconfirm its interesting bioactivities including low endotoxicity and activity against LPS-unresponsive C3H/HeJ mouse cells. RESULTS: The synthesized P. gingivalis lipid A (synthetic Pg-LA) exhibited strong activities almost equivalent to those of Escherichia coli-type synthetic lipid A (compound 506) in all assays on LPS-responsive mice, and cells. LPS and native lipid A of P. gingivalis displayed overall endotoxic activities, but its potency was reduced in comparison to the synthetic analogs. In the assays using C3H/HeJ mouse cells, the LPS and native lipid A significantly stimulated splenocytes to cause mitosis, and peritoneal macrophages to induce tumor necrosis factor-alpha and interleukin-6 production. However, synthetic Pg-LA and compound 506 showed no activity on the LPS-unresponsive cells. Inhibition assays using some inhibitors including anti-human Toll-like receptor 2 (TLR2) and TLR4/MD-2 complex monoclonal antibodies showed that the biological activity of synthetic Pg-LA was mediated only through the TLR4 signaling pathway, which might act as a receptor for LPS, whereas TLR2, possibly together with CD14, was associated with the signaling cascade for LPS and native lipid A of P. gingivalis, in addition to the TLR4 pathway. CONCLUSION: These results suggested that the moderated and reduced biological activity of P. gingivalis LPS and native lipid A, including their activity on C3H/HeJ mouse cells via the TLR2-mediated pathway, may be mediated by bioactive contaminants or low acylated molecules present in the native preparations having multiple lipid A moieties.
INTRODUCTION AND METHODS: A pentaacyl and diphosphoryl lipid A molecule found in the lipid A isolated from Porphyromonas gingivalislipopolysaccharide (LPS) was chemically synthesized, and its characteristics were evaluated to reconfirm its interesting bioactivities including low endotoxicity and activity against LPS-unresponsive C3H/HeJ mouse cells. RESULTS: The synthesized P. gingivalislipid A (synthetic Pg-LA) exhibited strong activities almost equivalent to those of Escherichia coli-type synthetic lipid A (compound 506) in all assays on LPS-responsive mice, and cells. LPS and native lipid A of P. gingivalis displayed overall endotoxic activities, but its potency was reduced in comparison to the synthetic analogs. In the assays using C3H/HeJ mouse cells, the LPS and native lipid A significantly stimulated splenocytes to cause mitosis, and peritoneal macrophages to induce tumor necrosis factor-alpha and interleukin-6 production. However, synthetic Pg-LA and compound 506 showed no activity on the LPS-unresponsive cells. Inhibition assays using some inhibitors including anti-human Toll-like receptor 2 (TLR2) and TLR4/MD-2 complex monoclonal antibodies showed that the biological activity of synthetic Pg-LA was mediated only through the TLR4 signaling pathway, which might act as a receptor for LPS, whereas TLR2, possibly together with CD14, was associated with the signaling cascade for LPS and native lipid A of P. gingivalis, in addition to the TLR4 pathway. CONCLUSION: These results suggested that the moderated and reduced biological activity of P. gingivalisLPS and native lipid A, including their activity on C3H/HeJ mouse cells via the TLR2-mediated pathway, may be mediated by bioactive contaminants or low acylated molecules present in the native preparations having multiple lipid A moieties.
Authors: Stephen R Coats; Alex B Berezow; Thao T To; Sumita Jain; Brian W Bainbridge; Karim P Banani; Richard P Darveau Journal: Infect Immun Date: 2010-10-25 Impact factor: 3.441
Authors: Svetislav S Zaric; Wilson A Coulter; Charles E Shelburne; Catherine R Fulton; Marija S Zaric; Aaron Scott; Mark J Lappin; Denise C Fitzgerald; Christopher R Irwin; Clifford C Taggart Journal: J Biol Chem Date: 2011-06-24 Impact factor: 5.157
Authors: James A Holden; Troy J Attard; Katrina M Laughton; Ashley Mansell; Neil M O'Brien-Simpson; Eric C Reynolds Journal: Infect Immun Date: 2014-07-21 Impact factor: 3.441
Authors: Yu-Hsiung Wang; Jin Jiang; Qiang Zhu; Amer Z AlAnezi; Robert B Clark; Xi Jiang; David W Rowe; Frank C Nichols Journal: Infect Immun Date: 2010-06-28 Impact factor: 3.441
Authors: Sumita Jain; Ana M Chang; Manjot Singh; Jeffrey S McLean; Stephen R Coats; Roger W Kramer; Richard P Darveau Journal: J Bacteriol Date: 2019-05-08 Impact factor: 3.490
Authors: Alex B Berezow; Robert K Ernst; Stephen R Coats; Pamela H Braham; Lisa M Karimi-Naser; Richard P Darveau Journal: Microb Pathog Date: 2009-05-19 Impact factor: 3.738